2026 Predictions for Clinical Labs: AI, Audits, and Increased Enforcement
How clinical laboratories should prepare for the next wave of oversight in the new year
How clinical laboratories should prepare for the next wave of oversight in the new year
This month’s roundup includes the continued court battle between BGI and Illumina, an FCA lawsuit, and the latest version of OSHA’s COVID-19 rule.
What happens when a whistleblower’s case is based on information that’s already been publicly disclosed?
The cost of recoveries hit an eight-year high in FY 2021, with the health care industry footing 90 percent of the bill.
Labs that bill federal health care programs for these tests need to pay especially close attention to ensure compliance.